期刊文献+

运用大陷胸汤异病同治解析 被引量:3

Exploration Thoughts of Treating Different Diseases with Same Daxianxiong Decoction
下载PDF
导出
摘要 目的:探析大陷胸汤异病同治的治疗思想。方法:采用文献整理的方法,以《伤寒杂病论》中论述大陷胸汤证条文为根据,参考近现代医家著作,从文献角度整合大陷胸汤异病同治思想。结果:大陷胸汤异病同治思想在近现代医家著作都有记载,对不同的疾病可以起到同样的治疗效果。结论:大陷胸汤的应用要着眼于临床,在临床的实践中掌握其运用。 Objective:To explore the treatment thoughts of treating different diseases with same daxianxiong decoction. Methods: Using the method of literature, on the basis of the terms discussion on daxianxiong decoction syndrome in " Treatise on Febrile and Miscellane- ous Diseases" , and reference the modern physicians works, and the thought of treating different diseases with same daxianxiong decoction was integrated from the perspective of the literatures. Results : The thought of treating different diseases with same daxianxiong decoction throughout the modem physicians works, and it can obtain the same curative effect on the treatment of different diseases. Conclusion: The application of daxianxiong decoction should focus on clinical, and master its use in clinical practice.
出处 《中医学报》 CAS 2013年第12期1825-1826,共2页 Acta Chinese Medicine
基金 河南省科技攻关项目(编号:2006360015)
关键词 大陷胸汤 异病同治 结胸证 daxianxiong decoction treating different diseases with same method jiexiong syndrome
  • 相关文献

参考文献9

二级参考文献37

  • 1姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 2岳茂兴,李成林,张连春,李学彪,张圭显,张诗琳.短程大剂量山莨菪碱及地塞米松救治外科危重病人186例[J].解放军医学杂志,1996,21(6):407-408. 被引量:37
  • 3Hu S, Sheng ZY, Zhou BT.Study on delay two phase multiple organ dysfunction syndrome. Chin Med J 1998, 111:101-108.
  • 4Poole GV, Muakkass FF, Griswold JA. The role of infection in outcome of multiple organ failure. Am Surg. 1993,59:727.
  • 5Cobb JP, O'Keefe GE. Injury research in the genomic era. Lancet 2004; 363:2076-2083.
  • 6Dellinger PR, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004,32:858- 873.
  • 7Bernard GR, Vincent JL, Laterre PF, LaRosa SP,Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
  • 8Keh D, Sprung CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidencebased review. Crit Care Med 2004, 32:S527-S533.
  • 9Chaudry IH, Hubbard WJ, Schwacha MG.Alterations in mitochondrial function following shock. Shock 2005,23:1-6.
  • 10姜玉峰 岳茂兴.解毒固本汤对CLP大鼠TNF、IL—2及病理形态学的影响[J].中国中西医结合学会急救医学杂志,2000,59:39-41.

共引文献6

同被引文献65

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部